↓ Skip to main content

Dove Medical Press

Article Metrics

Costs of medication in older patients: before and after comprehensive geriatric assessment

Overview of attention for article published in Clinical Interventions in Aging, April 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

twitter
51 tweeters
facebook
2 Facebook pages

Citations

dimensions_citation
45 Dimensions

Readers on

mendeley
97 Mendeley
Title
Costs of medication in older patients: before and after comprehensive geriatric assessment
Published in
Clinical Interventions in Aging, April 2018
DOI 10.2147/cia.s159966
Pubmed ID
Authors

Gulcin Done Unutmaz, Pinar Soysal, Busra Tuven, Ahmet Turan Isik

Abstract

Polypharmacy and inappropriate drug use cause numerous complications, such as cognitive impairment, frailty, falls, and functional dependence. The present study aimed to determine the effect of the comprehensive geriatric assessment (CGA) on polypharmacy, potentially inappropriate medications (PIMs) and potential prescribing omissions (PPOs), and to evaluate the economic reflections of medication changes. One thousand five hundred and seventy-nine older patients, who had undergone CGA, were retrospectively evaluated. The drugs, drug groups, and number of drugs that the patients used were recorded. Appropriate drug therapy was identified by both CGA and STOPP/START criteria. Based on these criteria, PIMs were discontinued and PPOs were started. The monthly cost of these drugs was calculated separately for PIMs and PPOs by using the drugstore records. After CGA, while the prevalence of non-polypharmacy was increased from 43.3% to 65.6%, the prevalence of polypharmacy and hyperpolypharmacy was decreased from 56.7% to 34.4% and 12.0% to 3.6%, respectively. The three most common PIMs discontinued were proton pump inhibitors, anti-dementia drugs, and antipsychotics, respectively. However, the most common PPOs started were vitamin D and B12 supplements, and anti-depressants. After CGA, monthly saved total per capita cost of PIMs was US$12.8 and monthly increased total per capita cost of PPOs was $5.6. It was demonstrated that prevalence of polypharmacy, PIM, and PPO could be decreased by CGA including START/STOPP criteria in older adults. Furthermore, this will have beneficial effects on economical parameters due to decreasing drug-related health care costs.

Twitter Demographics

The data shown below were collected from the profiles of 51 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 97 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 97 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 16 16%
Researcher 10 10%
Student > Bachelor 8 8%
Student > Ph. D. Student 8 8%
Student > Postgraduate 7 7%
Other 26 27%
Unknown 22 23%
Readers by discipline Count As %
Medicine and Dentistry 23 24%
Nursing and Health Professions 17 18%
Pharmacology, Toxicology and Pharmaceutical Science 13 13%
Business, Management and Accounting 3 3%
Agricultural and Biological Sciences 3 3%
Other 9 9%
Unknown 29 30%

Attention Score in Context

This research output has an Altmetric Attention Score of 30. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 May 2018.
All research outputs
#761,528
of 16,392,950 outputs
Outputs from Clinical Interventions in Aging
#78
of 1,550 outputs
Outputs of similar age
#23,598
of 283,247 outputs
Outputs of similar age from Clinical Interventions in Aging
#5
of 37 outputs
Altmetric has tracked 16,392,950 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,550 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 7.8. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 283,247 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.